Patent In $41M Contact Lens Suit Invalid: Re-Exam

The contact lens patent at the center of a lawsuit between Novartis AG unit CIBA Vision Corp. and Rembrandt Vision Technologies LP, which resulted in a $41 million verdict against CIBA...

Already a subscriber? Click here to view full article